Clinical Trials

    Genomic Translation for ALS Clinical Care

    Investigator: Stanley Appel

    Study Coordinator: Aramide Balogun

    Status: Open Not Enrolling

    ClinicalTrials.gov Number: NCT02795897

    Phone: 713.441.6955

    Protocol Number: Pro00015886

    Description


    The purpose of the this study to look for abnormal genes and gene expression profiles that help determine why a person develops amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MND) and why their symptoms present and progress with a particular pattern. [NCT=n/a]